Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2013
10/16/2013CN101589026B Method of treatment of glioma brain tumour
10/15/2013US8557876 Pyrimidine derivatives and their use in perfume compositions
10/15/2013US8557848 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
10/15/2013US8557834 Prolyl hydroxylase inhibitors
10/15/2013US8557832 Aryl methyl benzoquinazolinine M1 receptor positive allosteric modulators
10/15/2013US8557827 Pyrimidine derivatives and their use in perfume compositions
10/15/2013US8557826 Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions, and their use
10/15/2013US8557825 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/15/2013US8557808 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
10/15/2013US8557797 Triazolopyridine derivatives and their therapeutic use
10/15/2013CA2731273C Processes and intermediates for preparing retroviral protease inhibitors
10/15/2013CA2697256C Cyclopropyl amide derivatives
10/15/2013CA2592170C Glycine derivative and use thereof
10/15/2013CA2522319C N-[(piperazinyl)hetaryl]arylsulfonamide compounds and derivatives thereof with affinity for the dopamine d3 receptor
10/10/2013WO2013151923A1 Pyrimidinone carboxamides as inhibitors of endothelial lipase
10/10/2013WO2013151877A1 Pyrimidinedione carboxamide inhibitors of endothelial lipase
10/10/2013WO2013149977A1 1,2- pyridazine, 1,6- pyridazine or pyrimidine - benzamide derivatives as gpbar1 modulators
10/10/2013WO2013149581A1 Combination products with tyrosine kinase inhibitors and their use
10/10/2013WO2013120852A4 Intermediates for a novel process of preparing imatinib and related tyrosine kinase inhibitors
10/10/2013WO2013090454A3 Carboxylic acid derivatives comprising four cycles acting as glp-1 receptor modulators for therapy of diseases such as diabetes
10/10/2013US20130267546 Multifunctional Radical Quenchers and Their Uses
10/10/2013US20130267542 Histone deacetylases (hdacs) inhibitors
10/10/2013US20130267531 Salts of an epidermal growth factor receptor kinase inhibitor
10/10/2013US20130267530 Solid forms of an epidermal growth factor receptor kinase inhibitor
10/10/2013US20130267519 1,2-pyridazines, 1,6-pyridazines and pyrimidines
10/10/2013US20130267516 Substituted cyclopentyl-azines as casr-active compounds
10/10/2013US20130267492 Aryl sulfonamides
10/09/2013EP2647617A1 Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene
10/09/2013EP2646420A1 Method for the preparation of high-purity pharmaceutical intermediates
10/09/2013EP2646419A2 Method for preparing rosuvastatin salts
10/09/2013EP2646418A1 Pyrimidine derivatives and use thereof as pesticides
10/09/2013CN103347864A Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp - pla2
10/09/2013CN103347863A 改进的口服靶向药物递送系统 Improved oral drug delivery system targeting
10/09/2013CN103342682A Intermediate for preparing pyrimidine derivatives
10/09/2013CN102321033B Preparation method of tarceva
10/09/2013CN102295635B Antitumor medicament tetralin amide compounds and pharmaceutically acceptable salts thereof as well as preparation method and application of antitumor medicament tetralin amide compounds
10/08/2013US8552185 Preparation of azoxystrobin
10/08/2013US8552184 Compounds and methods for treating disorders related to glucose metabolism
10/08/2013US8552022 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
10/08/2013US8552020 N1-substituted-5-fluoro-2-oxopyrimidinone-1(2H)-carboxamide derivatives
10/08/2013US8552018 Substituted tricyclic compounds as protein kinase inhibitors
10/08/2013US8552017 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-A]pyrido-pyrimidine antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof
10/08/2013US8552016 Anti-cancer cyclopenta(g)quinazoline compounds
10/08/2013US8552015 Quinazolinone derivatives and their use as CB agonists
10/08/2013US8552002 Compounds and compositions as protein kinase inhibitors
10/08/2013US8551992 Aminooxazole inhibitors of cyclin dependent kinases
10/08/2013US8551981 Furo[3,2-d]pyrimidine compounds
10/08/2013CA2721222C Fungicidal active compound combinations
10/08/2013CA2634018C Pyrimidine derivatives
10/08/2013CA2531508C Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
10/03/2013WO2013147216A1 (2-heteroarylamino)succinic acid derivative
10/03/2013WO2013146437A1 3-decenoic acid derivative and use for same
10/03/2013WO2013144223A1 N-substituted pyrimidinylidene compounds and derivatives for combating animal pests
10/03/2013WO2013144187A1 5-aminopyrimidine derivatives and use thereof for combating undesired plant growth
10/03/2013WO2013144180A1 Heteroaryl compounds with cyclic bridging unit for use in the treatment helminth infection
10/03/2013WO2013143927A1 Co-crystals of dicamba and a co-crystal former b
10/03/2013WO2013143811A1 N-cyclylamides as nematicides
10/03/2013US20130261303 Process for the preparation of substituted cyanophenoxy-pyrimidinyloxy-phenyl acrylate derivatives
10/03/2013US20130261302 Agent for Inducing Endogenous Interferon
10/03/2013US20130261139 Use of a quinazoline compound in preparing a medicament against flaviviridae virus
10/03/2013US20130261135 Metalloenzyme inhibitor compounds
10/03/2013US20130261123 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
10/03/2013US20130261122 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
10/03/2013US20130261052 Inhibition of memapsin 1 cleavage in the treatment of diabetes
10/02/2013EP2644688A2 Novel pyrimidine derivatives and their use in perfume compositions
10/02/2013EP2644600A1 Heterocyclic aspartyl protease inhibitors
10/02/2013EP2644595A1 N-Cyclylamides as nematicides
10/02/2013EP2643416A1 The use of aryl or heteroaryl substituted dithiolene metal complexes as ir absorbers
10/02/2013EP2643305A1 Multicomponent system of rosuvastatin calcium salt and sorbitol
10/02/2013EP2643298A1 Substituted cyclopentyl - azines as casr- active compounds
10/02/2013EP2643294A2 An improved rilpivirine process
10/02/2013CN103339114A Benzyloxypyrimidine derivative, agricultural/horticultural insecticide comprising derivative and method for using same
10/02/2013CN103333125A Method for preparing quinazoline amine hydrochloride stable polymorphic substance
10/02/2013CN103333124A Preparation method of hydrochloric acid erlotinib crystal form F
10/02/2013CN103333123A Dehalogenation method for dihydrogen quinazoline ketone compound
10/02/2013CN103333122A Pinanyl-2-aminopyrimidine compounds as well as synthesis and application thereof
10/02/2013CN103333121A Fluorine-contained pyribenzoxim compound with herbicidal activity and preparation method thereof
10/02/2013CN103333120A Mesosulfuron-methyl synthetic method
10/02/2013CN103333119A 1,2-dihydro-6-methyl-4-substituted amino-5-pyrimidinecarboxylic acid compound and its preparation method and use
10/02/2013CN103333118A 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides
10/02/2013CN103333117A Preparation method of 4[(4-chloro-2-pyrmidyl)amino]cyanophenyl
10/01/2013US8546565 Quinazolinamide derivatives
10/01/2013US8546443 Benzylic oxindole pyrimidines
10/01/2013US8546429 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/01/2013US8546425 Folate receptor binding conjugates of antifolates
10/01/2013US8546405 Anti-viral compounds
10/01/2013US8546404 Compounds that are ERK inhibitors
10/01/2013US8546398 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/01/2013US8546392 17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases
10/01/2013CA2694242C Process for introduction of hydroxyethoxy side chain in bosentan
10/01/2013CA2607934C Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
10/01/2013CA2605323C Processes for the preparation of azoxystrobin using dabco as a catalyst and novel intermediates used in the processes
10/01/2013CA2565568C Pyrimidines as plk inhibitors
10/01/2013CA2541989C P70s6 kinase modulators and method of use
10/01/2013CA2532152C Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/01/2013CA2531507C Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
10/01/2013CA2506826C Uracils having a herbicidal activity
09/2013
09/26/2013WO2013140148A1 Quinazoline compounds and their use in therapy
09/26/2013US20130253195 Process for preparing bosentan monohydrate and its intermediated
09/26/2013US20130252986 Compounds
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 427